Phase
Condition
Respiratory Syncytial Virus (Rsv) Infection
Aging
Treatment
N/AClinical Study ID
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
•Adults able and willing to provide informed consent.
Specific inclusion criteria per group:
Young adults aged 18-30 years old
Healthy elderly aged >65 years old
Frail elderly >65 years old
Clinical Frailty score healthy elderly 1-3
Clinical Frailty score frail elderly >3
Self-reported respiratory tract infection in previous year healthy elderly 0-1
Self-reported respiratory tract infection in previous year frail elderly 0-1 or >1
Exclusion
Exclusion Criteria:
Incompetence to provide informed consent prior or during study
Current smoker or >40 pack year history
History of severe nose bleedings
Diagnosed with asthma, COPD or chronic rhinosinusitis
Use of inhalation corticosteroids or antibiotics in the past 6 weeks
Current use of anti-coagulants (to prevent nosebleeds). Platelet inhibitors likeacetylsalicylzuur (Ascal) are allowed.
Respiratory tract infection or common cold in the past 2 weeks
Immunocompromised individuals (with primary immune deficiency or secondary immunedeficiency)
Life expectancy <28 days in the opinion of study physician
Vaccination in the 2 months prior to study start. A potential subject that is onlyexcluded from participation based on a recent vaccination will be asked tore-participate 2 months post vaccination.
Study Design
Connect with a study center
Leiden University Medical Center
Leiden, Zuid Holland 2333ZA
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.